Home
http://www.virbac.fr/ http://www.boehringer-ingelheim.com/ http://www.novartis.com/ http://www.animalhealth.bayerhealthcare.com/
vetcontact
Vetrinär
Tiermedizin
  WELCOME  
vetcontact
Vetrinär
Tiermedizin
  Home  
  Login / Newsletter  
vetcontact
Vetrinär
Tiermedizin
  CONTACTS  
vetcontact
Vetrinär
Tiermedizin
  Classifieds  
  New Products  
  VetCompanies  
  VetSchools  
vetcontact
Vetrinär
Tiermedizin
  PROFESSION  
vetcontact
Vetrinär
Tiermedizin
  Edutainment  
  VetAgenda  
  Presentations  
  Posters  
  ESAVS  
  Specialisation  
vetcontact
Vetrinär
Tiermedizin
  INSIGHT  
vetcontact
Vetrinär
Tiermedizin
  Congress News  
  Picture Galleries  
vetcontact
Vetrinär
Tiermedizin
  PRODUCTS  
vetcontact
Vetrinär
Tiermedizin
  Bayer  
  Boehringer Ing.  
  Novartis  
  Virbac

 
  Simply book for less...  
    

Bovine    Equine    Small Animal Practice    Swine Practice    Articles    Vetjournal    
deutsch english español polski francais
Home / WELCOME / Archiv / Small Animal Practice /     
 
Pugs and mast cell tumours
Pugs are very special dogs. They seem to be at increased risk to develop mast cell tumours and these tumours tend to a special behaviour in this breed. An extremely important evaluation with surprising results!

Mast cell tumours (MCT) are common in dogs and characterized by diverse biologic behaviour.

Our objective was to evaluate the risk of MCT in pugs and to describe the clinical behaviour of MCT in this breed.

Data obtained from the Veterinary Medicine Database demonstrate significantly increased frequency of MCT in pugs compared with other dogs (OR = 2.28, 95% CI = 1.81–2.86).

The medical records for 25 purebred pugs with a histologic diagnosis of MCT were reviewed.

Multiple cutaneous tumours were documented in 14 (56 %) of the dogs.
Histologic review of 64 tumours from these dogs confirmed that most tumours (94%) were low to intermediate grade.

Sixty-four per cent of these dogs are still living, while only three dogs (12%) have died due to mast cell disease.

A median survival time has not been reached. The median follow-up time is 660 days from the diagnosis of the first MCT.

We conclude that MCT in pugs are relatively benign, despite the presence of multiple cutaneous tumours in most cases.

Multiple tumours in breeds with predisposition to MCT may indicate separate primaries rather than advanced stage disease.


Source: McNiel, E. A., Prink, A. L. & O`Brien, T. D. (2006): Evaluation of risk and clinical outcome of mast cell tumours in pug dogs. In: Veterinary and Comparative Oncology 4 (1), 2-8.




Tell a friend   |   Print version   |   Send this article

SMALL ANIMAL PRACTICE

RET-He to diagnose iron-deficient erythropoiesis in dogsmembers
Reticulocyte hemoglobin content provided by the Siemens ADVIA (CHr) is an established marker of iron deficiency. The IDEXX ProCyte Dx hematology analyzer now provides a similar variable, reticulocyte hemoglobin equivalent (RET-He).
The objectives of this study were to evaluate RET-He and its diagnostic utility in dogs, and to calculate a cutoff value for diagnosing iron-deficient erythropoiesis (IDE).

  • Platelet indices in dogs with septic peritonitis
  • Hypertriglyceridemia-Associated Proteinuria in Miniature Schnauzersmembers
  • Gastrointestinal dysmotility disorders in critically ill animalsmembers
  • Disorder of sex development in a cat with chromosome mosaicism members
  • Generalized discoid lupus erythematosus in dogs members
  • Epidermolysis bullosa acquisita in dogsmembers
  • Chiari-Like Malformation and Syringomyelia in American Brussels Griffon Dogsmembers
  • Efficacy and Potential Complications of Transjugular Liver Biopsymembers
  • Hypomagnesemia in Brachycephalic Dogsmembers
  • Comparison of two minimally invasive techniques for liver biopsy members
  • Topical aqueous sirolimus and the tear production members
  • JAK 1/2 inhibitor in the treatment of canine B-cell lymphomamembers


  • [ Home ] [ About ] [ Contact / Request ][ Disclaimer ]

    Copyright © 2001-2016 VetContact GmbH
    All rights reserved